Correlation Between Dupont De and Isracann Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Isracann Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Isracann Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Isracann Biosciences, you can compare the effects of market volatilities on Dupont De and Isracann Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Isracann Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Isracann Biosciences.

Diversification Opportunities for Dupont De and Isracann Biosciences

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Dupont and Isracann is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Isracann Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isracann Biosciences and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Isracann Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isracann Biosciences has no effect on the direction of Dupont De i.e., Dupont De and Isracann Biosciences go up and down completely randomly.

Pair Corralation between Dupont De and Isracann Biosciences

Allowing for the 90-day total investment horizon Dupont De is expected to generate 28.03 times less return on investment than Isracann Biosciences. But when comparing it to its historical volatility, Dupont De Nemours is 39.87 times less risky than Isracann Biosciences. It trades about 0.05 of its potential returns per unit of risk. Isracann Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1.10  in Isracann Biosciences on September 2, 2024 and sell it today you would lose (1.10) from holding Isracann Biosciences or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Dupont De Nemours  vs.  Isracann Biosciences

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Isracann Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isracann Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Dupont De and Isracann Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Isracann Biosciences

The main advantage of trading using opposite Dupont De and Isracann Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Isracann Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isracann Biosciences will offset losses from the drop in Isracann Biosciences' long position.
The idea behind Dupont De Nemours and Isracann Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency